GP-45795: a controlled evaluation in chronic schizophrenic patients.
D000328:Adult; D000704:Analysis of Variance; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D002986:Clinical Trials as Topic; D003988:Dibenzothiepins / Q000009:adverse effects / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D005260:Female; D005650:Fumarates / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy; D014268:Trifluoperazine / Q000627:therapeutic use
D003988:Dibenzothiepins; D005650:Fumarates; D010879:Piperazines; D014268:Trifluoperazine